Cite
Metabolism of the failing heart and the impact of SGLT2 inhibitors
MLA
Juan J. Badimon, et al. “Metabolism of the Failing Heart and the Impact of SGLT2 Inhibitors.” Expert Opinion on Drug Metabolismtoxicology, vol. 15, no. 4, Mar. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75c24077d7ed008e3aea28bfb694ffb2&authtype=sso&custid=ns315887.
APA
Juan J. Badimon, M. Urooj Zafar, Carlos G. Santos-Gallego, & Alvaro Garcia-Ropero. (2019). Metabolism of the failing heart and the impact of SGLT2 inhibitors. Expert Opinion on Drug Metabolismtoxicology, 15(4).
Chicago
Juan J. Badimon, M. Urooj Zafar, Carlos G. Santos-Gallego, and Alvaro Garcia-Ropero. 2019. “Metabolism of the Failing Heart and the Impact of SGLT2 Inhibitors.” Expert Opinion on Drug Metabolismtoxicology 15 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75c24077d7ed008e3aea28bfb694ffb2&authtype=sso&custid=ns315887.